Question 1

What is Nektar Therapeutics's accrued expenses?

Accepted Answer

Nektar Therapeutics (NKTR) reported accrued expenses of $5.01M in Q1 2026.

Question 2

How has Nektar Therapeutics's accrued expenses changed year-over-year?

Accepted Answer

Nektar Therapeutics's accrued expenses decreased by 0.4% year-over-year, from $5.03M to $5.01M.

Question 3

What is the long-term trend for Nektar Therapeutics's accrued expenses?

Accepted Answer

Over 5 years (2020 to 2025), Nektar Therapeutics's accrued expenses has grown at a -27.4% compound annual growth rate (CAGR), from $14.53M to $2.94M.

Question 4

What does accrued expenses mean?

Accepted Answer

Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.

Line item	March 31, 2026	December 31, 2025
Accrued research and development expenses	$13,021	$13,980
Accrued compensation	5,008	2,940
Accrued contract termination costs	3,065	2,632
Other accrued expenses	4,057	2,719
Total accrued expenses	$25,151	$22,271

Accrued Expenses at other companies

Other financials